Alkermes Management
Management criteria checks 3/4
Alkermes' CEO is Richard Pops, appointed in Sep 2011, has a tenure of 13.17 years. total yearly compensation is $9.44M, comprised of 12.5% salary and 87.5% bonuses, including company stock and options. directly owns 0.73% of the company’s shares, worth $32.92M. The average tenure of the management team and the board of directors is 5.5 years and 3.9 years respectively.
Key information
Richard Pops
Chief executive officer
US$9.4m
Total compensation
CEO salary percentage | 12.5% |
CEO tenure | 13.2yrs |
CEO ownership | 0.7% |
Management average tenure | 5.5yrs |
Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Alkermes plc's (NASDAQ:ALKS) Low P/E No Reason For Excitement
Oct 14Is Alkermes (NASDAQ:ALKS) A Risky Investment?
Sep 17Alkermes: Fairly Valued After Post-Earnings Bump
Jul 28Does Alkermes (NASDAQ:ALKS) Deserve A Spot On Your Watchlist?
Jul 26Alkermes plc's (NASDAQ:ALKS) Business And Shares Still Trailing The Industry
Jul 04The Bottom Fishing Club: Alkermes Has Great Value And Safety
May 17Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals
May 08Alkermes: Waking Up Narcolepsy Treatment With Promising Trial Data
Apr 09Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Apr 08Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet
Jan 26Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?
Nov 01Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point
Nov 01Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?
Jul 15There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding
Jun 07Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?
Apr 10Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Mar 20Alkermes upgraded to neutral at BofA on improved risk/reward outlook
Oct 14Alkermes holder Sarissa Capital says it may look to increase its stake
Oct 07Alkermes: Nothing Stands Out As Interesting
Sep 26Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?
Aug 29Alkermes initiated at neutral at Piper Sandler as company in transition
Aug 16Alkermes Q2 2022 Earnings Preview
Jul 26Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?
Jun 27Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?
May 16Alkermes: Turning The Tides Towards Profitability
Apr 16CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | US$387m |
Jun 30 2024 | n/a | n/a | US$386m |
Mar 31 2024 | n/a | n/a | US$570m |
Dec 31 2023 | US$9m | US$1m | US$519m |
Sep 30 2023 | n/a | n/a | US$455m |
Jun 30 2023 | n/a | n/a | US$300m |
Mar 31 2023 | n/a | n/a | -US$9m |
Dec 31 2022 | US$10m | US$1m | -US$33m |
Sep 30 2022 | n/a | n/a | -US$129m |
Jun 30 2022 | n/a | n/a | -US$94m |
Mar 31 2022 | n/a | n/a | -US$62m |
Dec 31 2021 | US$9m | US$1m | US$76m |
Sep 30 2021 | n/a | n/a | -US$92m |
Jun 30 2021 | n/a | n/a | -US$63m |
Mar 31 2021 | n/a | n/a | -US$95m |
Dec 31 2020 | US$8m | US$1m | -US$111m |
Sep 30 2020 | n/a | n/a | -US$74m |
Jun 30 2020 | n/a | n/a | -US$126m |
Mar 31 2020 | n/a | n/a | -US$139m |
Dec 31 2019 | US$15m | US$1m | -US$197m |
Sep 30 2019 | n/a | n/a | -US$201m |
Jun 30 2019 | n/a | n/a | -US$183m |
Mar 31 2019 | n/a | n/a | -US$173m |
Dec 31 2018 | US$17m | US$1m | -US$139m |
Sep 30 2018 | n/a | n/a | -US$139m |
Jun 30 2018 | n/a | n/a | -US$141m |
Mar 31 2018 | n/a | n/a | -US$152m |
Dec 31 2017 | US$9m | US$964k | -US$158m |
Compensation vs Market: Richard's total compensation ($USD9.44M) is above average for companies of similar size in the US market ($USD6.57M).
Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.
CEO
Richard Pops (62 yo)
13.2yrs
Tenure
US$9,442,066
Compensation
Mr. Richard F. Pops has been the Chief Executive Officer and Director of Alkermes PLC since September 2011 and its Chairman since September 16, 2011. Mr. Pops was the Founder of Genomics Collaborative, Inc...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 13.2yrs | US$9.44m | 0.73% $ 32.9m | |
Interim Principal Financial Officer | 3.8yrs | US$4.56m | 0.098% $ 4.4m | |
Executive VP | 8.5yrs | US$4.14m | 0.10% $ 4.6m | |
Senior VP & CFO | less than a year | US$3.21m | 0.072% $ 3.2m | |
Executive VP of Research & Development and Chief Medical Officer | 7.5yrs | US$4.23m | 0.051% $ 2.3m | |
Founder | no data | US$324.96k | no data | |
Interim Principal Accounting Officer & VP of Finance | less than a year | no data | 0.0048% $ 215.4k | |
Chief Information Officer & Senior VP of IT | 6.6yrs | no data | no data | |
Senior Vice President of Corporate Affairs & Investor Relations | no data | no data | no data | |
Senior VP & Chief Human Resources Officer | 4.4yrs | no data | no data | |
Senior Vice President of Policy & Government Relations | no data | no data | no data | |
Senior Vice President of Operations and Environment | no data | no data | no data |
5.5yrs
Average Tenure
55yo
Average Age
Experienced Management: ALKS's management team is seasoned and experienced (5.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 13.2yrs | US$9.44m | 0.73% $ 32.9m | |
Independent Director | 3.9yrs | US$482.04k | 0.023% $ 1.1m | |
Independent Director | 8.5yrs | US$482.04k | 0.016% $ 709.4k | |
Independent Director | less than a year | no data | no data | |
Independent Director | 6.7yrs | US$449.04k | 0.062% $ 2.8m | |
Independent Director | 3.9yrs | US$474.04k | 0.067% $ 3.0m | |
Independent Director | 3yrs | US$459.04k | 0.012% $ 552.7k | |
Lead Independent Director | 5.2yrs | US$486.65k | 0.015% $ 697.7k | |
Independent Director | 2.5yrs | US$463.12k | 0.0089% $ 402.4k | |
Independent Director | 5.2yrs | US$464.69k | 0.015% $ 697.7k | |
Independent Director | 3.5yrs | US$469.04k | 0.017% $ 761.8k |
3.9yrs
Average Tenure
62yo
Average Age
Experienced Board: ALKS's board of directors are considered experienced (3.9 years average tenure).